Instinct Bio Technical Company Holdings Inc. BIOT
0.18 USD 0.00 (-0.54%)
Nov 4, 2026, 2:56 PM EST
0.1825 Day range 0.1906
0.17 52-week range 50.00
- YTD
- -98.81%
- 1 year
- -98.81%
- Market cap
- 5.31M
- EPS (ttm)
- -0.01
- Shares out
- 23.00M
- YTD return
- -98.81%
- 1-year return
- -98.81%
- Volume
- 46.34K
- Avg volume
- 425.22K
- Open
- 0.1826
- Previous close
- 0.1855
- Day's range
- 0.1825 – 0.1906
- 52-week range
- 0.17 – 50.00
2Y -15.3143 (-98.80%)
Key statistics
- Enterprise value
- 297.00M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 13.14K
- Total debt
- 308.35K
- Return on equity
- 0.00%
- Short % of float
- 0.04%
- 50-day average
- 10.12
- 200-day average
- 9.94
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
BIOT Revenue — quarterly 0
BIOT Net income — quarterly 1.26M
BIOT EPS — quarterly 0.04
About Instinct Bio Technical Company Holdings Inc.
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
News
INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives Instinct Bio Enters Cooperation Agreement With Indonesian Cosmetics Manufacturer Parva To Jointly Develop Indonesia’s Cosmetics And Personal Care Market
Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia Instinct Bio Technical Plans To Roll Out Its Japanese Aesthetic Care Brand GENREVER CLINIC To Indonesia; Introduce Subscription-Model Membership Beauty Clinic Operations
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
Instinct Bio Stock Slides After Hours: Here's What is Going on With BIOT
Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth
Your note
Sign in to keep a note on BIOT — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Glazer Capital LLC | 9.93% | 2,285,000 | 23.19M | Sep 29, 2022 |
| Hudson Bay Capital Management Lp | 5.49% | 1,261,609 | 12.81M | Sep 29, 2022 |
| Aristeia Capital, LLC | 5.00% | 1,149,010 | 11.66M | Sep 29, 2022 |
| Marshall Wace LLP | 4.40% | 1,012,642 | 10.28M | Sep 29, 2022 |
| Saba Capital Management, L.P. | 4.20% | 965,348 | 9.80M | Sep 29, 2022 |
| Corbin Capital Partners, LP | 4.04% | 928,124 | 9.42M | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RiverPark Fds Tr-RiverPark Short Term High Yield Fd | 3.47% | 799,001 | 8.11M | Sep 29, 2022 |
| Merger Fund, The | 1.89% | 434,517 | 4.41M | Sep 29, 2022 |
| Saba Capital Income & Opportunities Fd | 0.48% | 109,702 | 1.11M | Oct 30, 2022 |
| RiverNorth Opportunities Fd | 0.21% | 47,978 | 486.98K | Oct 30, 2022 |
| WCM Alternatives Event Driven Fd | 0.16% | 35,852 | 363.90K | Sep 29, 2022 |
| RiverNorth Specialty Finance Corporation | 0.10% | 21,998 | 223.28K | Sep 29, 2022 |
